Navigation Links
3D Atlas Will Help Navigate The Spinal Cord

Professor George Paxinos and Dr Yuri Koutcherov of the Spinal Injuries Research Centre at the Prince of Wales Medical Research Institute have been awarded ~$200,000 by the Christopher Reeve Paralysis Foundation to prepare a three-dimensional (3D) atlas of the rat spinal cord over the next two years.

Christopher Reeve met with Institute scientists during his visit to Australia in 2003 and was impressed with their work in spinal injuries research. Professor Paxinos is a world leader in the preparation of brain atlases, being the author of atlases of human, monkey, rat and mouse brains used world-wide by neuroscientists in all areas.

As a geographic map to a traveller, a map of the spinal cord is needed by scientists studying the spinal cord of humans. Currently the principal animal for spinal cord injury research is the rat. There is no comprehensive and accurate atlas of the rat spinal cord; indeed, the problem is greater: there is no comprehensive structural study of the spinal cord of any species, including humans.

A new project supported by the Christopher Reeve Paralysis Foundation is designed to redress this shortcoming. The results will provide (a) the fundamental structural map of the rat spinal cord, (b) make relevant comparisons with the human spinal cord and demonstrate the anatomical principles or generalizations of its organization, and (c) provide the 3D stereotaxic space designed to become the knowledge management environment for experimental and, eventually, clinical observations.

Though not itself directed at a cure for the consequences of spinal cord injury, the project will accelerate progress of such research because it will permit scientists to navigate seamlessly between the rat and human spinal cords to test hypotheses inspired by human considerations and relate data from experiments in animals back to humans.

The proposed description of the structure of the spinal cord will be based on a comprehensive use of neurochemical markers (chemoarchitecture). Many pathways in the nervous system contain a particular protein which can be demonstrated in tissue sections using a technique called immunohistochemistry that involves the use of specific antibodies. The often distinct distribution of these chemicals in the rat spinal cord is like a "signature" for one type of nerve cell and its processes.

Because most of the neurochemical proteins are conserved across species, they are present not only in a particular group of nerve cells in the rat, but also in its homologue (corresponding structure) in the human. The study will, for the first time, comprehensively depict transverse and horizontal sections, reproduce these in 3D and make some parallel observations in the human spinal cord (when tissue becomes available), thus supporting both experimental and clinical approaches.


'"/>

Source:Prince of Wales Medical Research Institute


Related biology news :

1. Spinal cord bridge bypasses injury to restore mobility
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology: